Ligand Pharmaceuticals tem EPS Non-GAAP de US$ 2,67, supera em US$ 0,34; receita de US$ 78,75 mi supera em US$ 1,52 mi
Ligand Pharmaceuticals press release (LGND): Q3 Non-GAAP EPS of $2.67 beats by $0.34.Revenue of $78.75M (-31.8% Y/Y) beats by $1.52M.Ligand is raising its...